logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Galena Biopharma (GALE) Plunges as Concerns over Scandal Continue

By  +Follow February 14, 2014 5:26AM
Share:
Tickers Mentioned:

Share in Galena Biopharma (GALE) plunged nearly 25 percent to begin trading Friday on heavy volume as the fallout from the company’s stock promotion scandal appears to continue. The sell-off appeared to break through a major technical barrier that had developed in recent months, causing the drop to pick up steam as the morning wore on.

GALE Hammered Again on Heavy Volume

Shares of Galena were moving fast on Friday morning as the stock went into freefall soon after the opening bell. Without any specific news appearing to drive the drop, the sell-off appears to be motivated by speculators, residual negative sentiment from Wednesday’s revelations that the company was paying a marketing firm to pump its stock, or some combination of both.

The fall paused briefly at 10 am after the stock reached $4 a share, a price that had been acting as a support level since mid-December. However, after circling the drain for about 15 minutes, the selling resumed and Galena appeared to break through said support level firmly. Shares then kept falling, reaching $3.30 a share before starting to bounce back just after 11 am.

Pipeline Must Produce

The good news for Galena investors is that the company currently has what appears to be a robust product pipeline in place. Oral pain treatment Abstral has already been approved for use in the market and was officially launched in October. However, some Galena shorts estimate that the drug’s 5 percent market share will ultimately only net $20 million to $30 million for Galena.

Meanwhile, the company also has three different drugs currently in various stages of development: NeuVax, GALE-401, and GALE-301, a Folate Binding Protein vaccine for ovarian and endometrial cancer patients. NeuVax is currently in two separate trials to test its efficacy in treating breast cancer (one is testing the drug in combination with Herceptin), with a third trial in planning to test its effect on gastric cancer patients.

Galena’s website describes NeuVax as follows: “NeuVax consists of the E75 peptide derived from HER2 combined with the immune adjuvant granulocyte macrophage colony stimulating factor (GM-CSF).  Treatment with NeuVax stimulates cytotoxic (CD8+) T cells in a highly specific manner to target cells expressing any level of HER2.  NeuVax is given as an intradermal injection once a month for six months, followed by a booster injection once every six months.”

Herceptin, which is only available as a treatment to a quarter of women affected by breast cancer, had revenues of $5 billion in 2010, giving Galena hope that sunnier days are around the corner. However, the recent revelations of stock promotion may place extra pressure on future clinical results for the company.

Noble Financial’s Endorsement Not a Timely One

The plummeting share price for Galena comes just two weeks after Noble Financial reiterated its buy rating on the stock and raised the price target from $4 to $6 a share.

“With improved pk metrics GALE-401 may be more effective without the tolerability/safety issues of Anagrelide-IR; could capture larger market share over HU; US sales potential of $150 to $200M; 8K new cases of ET each year and 80-100K prevalence in US ... Company has discussed with FDA, GALE-401 will be developed under 505b2 path for ET with Anagrelide-IR as reference drug; Phase 2 studies to begin shortly; could be on the market late 2017 or early 2018,” Analyst Rahul Jasuja noted.

Analysts have been kind to Galena in 2014, with two other analysts weighing in on Tuesday, Jan. 21. Maxim Group rated the stock a buy and raised its price target from $9 to $11, while Needham & Company increased their own price target to $9 a share. That makes five different research analysts rating the stock a buy, and the average price target for the company is $7.64 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for GALE
OTPicks.com
30 Sep 14 20:05:30
http://t.co/hjgLwIcNgz DennyT: GS Industry $GS $TA $GALE $SVXY $VPOR Buy or Sell: DennyT http://t.co/Vu4xL0BglU http://t.co/hjgLwIcNgz
Kenneth Edwards
30 Sep 14 19:10:59
@adamfeuerstein @bnichols9883 This is the pot calling the kettle black $GALE $PCYC $SRPT $ICPT $ARNA $OMED $REGN $CELG $CPRX
alexander
30 Sep 14 16:06:34
Commented on StockTwits: These analysts are bloody TOOLS! he was issuing buy rating with PT 11 when $CYTR & $GALE... http://t.co/CrPZpzRotx
Stockaholics
30 Sep 14 15:48:45
FPFI closed up 250% today! Huge Update and new pick coming: http://t.co/wSPWepHL5n $ETEK $GALE $RSOL
Lucretia
30 Sep 14 15:01:16
$GALE Galena Biopharma Inc. (GALE) Leads Small-Cap Stars in Early Trading for ... http://t.co/7s39GoDtxU
Stephen s
30 Sep 14 13:56:53
RT @danrocks4: $GALE any other opinions on this? $GILD $MYEC $AMAG $FXI $AA http://t.co/AevpfZflGn
alexander
30 Sep 14 12:44:14
$GALE it's going to trigger stoploss points...
Investors Hangout
30 Sep 14 10:44:46
DennyT: UVXY Basic Tech. Analysis $UVXY $GALE $MYEC $DGAZ http://t.co/rUA1JghgaR
Investors Hangout
30 Sep 14 10:44:44
DennyT: UVXY Basic Tech. Analysis $UVXY $GALE $MYEC $DGAZ http://t.co/6j8Oi4w20t
DennyT
30 Sep 14 10:11:22
UVXY Basic Tech. Analysis $UVXY $GALE $MYEC $DGAZ $BBRY Opinion,Daily Chart,Volume,Recent News,Alert Stock Quo http://t.co/vik9DedJnJ
Investors Hangout
30 Sep 14 09:59:51
danrocks: $GALE any other opinions on this? $GILD $MYEC http://t.co/bisTL80G8v
Investors Hangout
30 Sep 14 09:59:17
danrocks: $GALE any other opinions on this? $GILD $MYEC http://t.co/u6rpoPHzGs
danrocks
30 Sep 14 09:57:30
$GALE any other opinions on this? $GILD $MYEC $AMAG $FXI $AA http://t.co/AevpfZflGn
Investors Hangout
30 Sep 14 09:40:08
DennyT: GS Industry $GS $TA $GALE $SVXY $VPOR Buy or Sell http://t.co/CE1Vtvj9ru
Investors Hangout
30 Sep 14 09:39:44
DennyT: GS Industry $GS $TA $GALE $SVXY $VPOR Buy or Sell http://t.co/nLZght0Smo
iHangout
30 Sep 14 09:32:41
http://t.co/vVojvVrNNL DennyT: ALERTS, HOT STOCKS & CHARTS: GS Industry $GS $TA $GALE $SVXY $VPOR Buy or Sell http://t.co/ojkX6k6cQx
DennyT
30 Sep 14 09:26:37
GS Industry $GS $TA $GALE $SVXY $VPOR Buy or Sell Opinion,200 Simple Moving Average,Low,Recent News,Hitting Bu http://t.co/Dznhsfqk5n
danrocks
30 Sep 14 09:03:07
$XLY alot of talk going around about this one $DKGR $WAG $GALE $FITX $FITX http://t.co/HGsYfspONY
leahanne
30 Sep 14 08:30:42
$UGAZ 3X Long Natural Gas ETN Velocityshares (UGAZ) 16.15 +0.09 (+0.56%) $GALE $USO $AXCG http://t.co/ywxVQARyha
Investors Hangout
30 Sep 14 08:04:49
lookn4wins: $GALE Stock Chart $GALE Most recent stock chart http://t.co/KDONK1t9hJ
Investors Hangout
30 Sep 14 08:00:03
lookn4wins: $GALE Stock Chart $GALE Most recent stock chart http://t.co/iiqkPsm2t5
lookn4wins
30 Sep 14 07:37:43
$GALE Stock Chart $GALE Most recent stock chart and technical analysis. $BIDU $EBAY $IYT $ELRA $MU $GALE http: http://t.co/tpq3SNY9mc
Alex Galan
30 Sep 14 06:36:15
$GALE +0.02 0.95% watching
PennyStock Zone
30 Sep 14 06:07:22
I am a VERY HAPPY subscriber to SUPERTRADES service check it out http://t.co/Ho9ydXHTWl $gale $twtr $aapl $lnkd $wfm $bac $cbis $mu #stocks
Thomas Collins
30 Sep 14 05:01:35
$GALE Why Galena Biopharma, Inc. Stock Crashed By 52% in 2014 http://t.co/A4OJTxO1Jd
alexander
30 Sep 14 04:23:34
Commented on StockTwits: $GALE even a Weather Man can do better than Joseph Pantginis ... :-) http://t.co/KRnkbILbNX
alexander
30 Sep 14 04:19:50
$GALE What to expect when Joseph Pantginis @ Roth Capital issues a PT and buy Rating -20.70% return http://t.co/SvDM0cFyAZ
TipRanks
30 Sep 14 03:14:00
0-star analyst Joseph Pantginis from Roth Capital reiterated a BUY rating on $GALE. Joseph has a 30.6% success rate http://t.co/LdjYNOCOwT
Stockaholics
29 Sep 14 23:38:58
$VOIS gained 218.52% in less than 3 weeks, after our Penny Stock Alerts! Major Update: http://t.co/HglCNdSVSO $ETEK $GALE $RSOL
LeprechaunAlert
29 Sep 14 22:42:01
$SONS $CYTR $SNTA $SVA $NEWL $GALE $SQNM $PSDV $OREX $SCOK $NETE $HERO $ECEL $FREE $GEVO $CNET $BAXS $END $ZNGA
$$$ Money $$$
29 Sep 14 21:19:49
$AEZS $DARA $GALE $PRAN $KBIO $TRGT $ETRM all bios turd. I hate them all. Dont ask my opinion cuz i hate them all lol http://t.co/aOAkyQ1RLB
Stockaholics
29 Sep 14 14:44:30
$VOIS gained 218.52% in less than 3 weeks, after our Penny Stock Alerts! Major Update: http://t.co/LcBxWgdLUh $ETEK $GALE $RSOL
Smarter Analyst
29 Sep 14 12:37:10
$GALE Roth Capital Reiterates Buy On Galena Following Release Of Special Committee Report http://t.co/DAllmAXSGM
BuyersStrike
29 Sep 14 12:17:47
@Regarded49 @CopaDelMundo7 The crack Alan was smoking when he fawned all over $GALE and their chief pump officer Mark Ahn?
SIAnalystWire
29 Sep 14 10:49:31
Roth Lowers Ests on Galena Biopharma $GALE Following Special Committee Report http://t.co/wZhPLgKnDZ
Stockaholics
29 Sep 14 09:09:46
Subscribe to our penny stock newsletter, for FREE! We have some huge picks on the way: http://t.co/buedBpPSUK $ETEK $GALE $RSOL
justamoneymatter
29 Sep 14 06:50:09
$GALE trying
justamoneymatter
29 Sep 14 05:58:01
"@moneymatter: weekly trades recap http://t.co/TSxldmM7j6 $CREG $HPJ $FORD $ATOS $CYTR $IMMU $RSH $OTIV $GALE $ICLD $HIMX $OBCI $CREG"
justamoneymatter
29 Sep 14 05:18:46
weekly trades recap http://t.co/zJhGZ3QEMl $CREG $HPJ $FORD $ATOS $CYTR $IMMU $RSH $OTIV $GALE $ICLD $HIMX $OBCI $CREG
Homegameralert
29 Sep 14 04:39:13
some small bios with great news and pipelines, check out $EXEL, $GALE, $CNAT, $ANIP, $EPRS, and $ATRS
Dan
29 Sep 14 03:51:15
$GALE Max Pain is 3.00 for maturity 10/18/2014. Last close = 2.13. http://t.co/8BexpnbyMd
Stockaholics
28 Sep 14 19:38:38
Subscribe to our penny stock newsletter, for FREE! We have some huge picks on the way: http://t.co/buedBpPSUK $ETEK $GALE $RSOL
PennyStock Zone
28 Sep 14 15:16:36
I am a VERY HAPPY subscriber to SUPERTRADES service check it out http://t.co/Ho9ydXHTWl $gale $twtr $aapl $lnkd $wfm $bac $cbis $mu #stocks
Eric Zakarin
28 Sep 14 12:07:52
RT @VFA_SCF: @adamfeuerstein doomed to Jail? Will the #SEC #DOJ protect shareholders from short predators? $GALE $NWBO $MNKD http://t.co/u…
ChocoFlavRoastBeef
28 Sep 14 12:02:17
@adamfeuerstein doomed to Jail? Will the #SEC #DOJ protect shareholders from short predators? $GALE $NWBO $MNKD http://t.co/uVJchm1LBU
Cedric Invest
28 Sep 14 10:00:16
$GALE Maxim Group Maintains Buy On Galena Biopharma Following Conference Call http://t.co/lpKMR6Cg21
Eric Zakarin
28 Sep 14 09:29:49
RT @VFA_SCF: Great article | Biotech reporter @adamfeuerstein concedes he may be exchanging information with shorts. $GALE $NWBO http://t…
StockKingz
28 Sep 14 05:34:23
After hours movers to Watch MondayMorn- $alim $psdv $tnxp $sgen $fnjn $otiv $kite $gale $study $BIOF #trading #stocks http://t.co/ogFNHPWIDz
Dr. Fred Feuerbach
28 Sep 14 04:19:01
RT @VFA_SCF: Great article | Biotech reporter @adamfeuerstein concedes he may be exchanging information with shorts. $GALE $NWBO http://t…
Stockaholics
28 Sep 14 02:56:55
Subscribe to our penny stock newsletter, for FREE! We have some huge picks on the way: http://t.co/buedBpPSUK $ETEK $GALE $RSOL
				
				
By  +Follow February 14, 2014 5:26AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.